The answer isn’t so clear-cut.
In a recent article, the Wall Street Journal wrote a nice overview of Shutterstock’s role as “the Web’s best-performing photo gallery,” and how it “has been used by bloggers to raise money, as a way to sell posters to events, and as an advertising tool for companies—its customers include many major media corporations.” In all, it says, “Photographers, photo-store users and other Web users increasingly use Shutterstock.”
A pair of New York State Assembly members are planning to reintroduce legislation which would allow for the licensing of edible cannabidiol and marijuana extracts used in medical marijuana studies from the state.
Assemblywoman Cheryl Roberts and State Representative John Wisniewski (D) introduced an Assembly Bill (A.B. 2187) on the 16th, 21st and 10th day of the current legislative session to the New York State Senate. State Senator Jeffrey Klein (D) introduced the bill to the Assembly Judiciary Committee.
Both members have previously sponsored A.B. 633 which would have removed edible cannabidiol/marijuana extracts from the state’s list of drugs and eliminated the criminalization of cannabidiol/marijuana use if a patient obtained the necessary prescription cards. Both bills failed, with the Senate overriding the veto. A.B. 633 would not have applied to patients who are under 18 years old, as well as patients already under age 21.
While there is still no timeline for the House and Senate to return to session to vote on A.B. 2187, the legislators said they are still hopeful this will be their first bill passing out of both chambers.
A press release from the two indicated, “This legislation is important to our constituents, as it will give them the option of a healthier alternative to the dangerous marijuana they’ve seen on TV and in the news, along with allowing physicians to prescribe it if required.”
Roberts and Wisniewski’s bill would also eliminate the ban on using cannabidiol and extracts for medicinal purposes for people 21 years of age and older.
“New York State has become a pioneer on the world of cannabis research and treatment and should be applauded for this,” said Roberts. “It’s time to do the same for cannabidiol, or cannabidiol-derived medicine, and the people in the state of New York should be able to do this as well.”